Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group
Conclusions
Except for the risk of premature ovarian failure, a rare adverse effect of combined treatments, both single-agent and multiagent chemotherapy can be safely administered to patients with a desire for childbearing. High-risk patients have worse reproductive outcomes because they undergo hysterectomy more frequently than low-risk patients.
Source: International Journal of Gynecological Cancer - Category: Cancer & Oncology Tags: Gestational Cancer Source Type: research
More News: Amenorrhea | Cancer | Cancer & Oncology | Chemotherapy | Gestational Trophoblastic Tumor | Hysterectomy | Infertility | Men | Menopause | Miscarriage | OBGYN | Ovarian Cancer | Ovaries | Pregnancy | Premature Birth | Reproduction Medicine | Study | Women